Analysis of influencing factors of pancreatitis after duodenoscopic common bile duct stone removal surgery

doi:10.11958/20240978

Abstract

Abstract:

Objective To explore the influencing factors of pancreatitis after duodenoscopic common bile duct stone removal surgery (DCBDSR). Methods A total of 387 patients with DCBDSR were included in this study. Patients were divided into the pancreatitis group (36 cases) and the non-pancreatitis group (351 cases). General data and laboratory indexes were compared between the two groups. The influencing factors of postoperative pancreatitis after DCBDSR were analyzed by regression analysis. Results Compared with the non-pancreatitis group, the pancreatitis group had a younger age, a higher proportion of hypertension, hyperlipidemia and pancreatic history, and a higher average number of intubations (P < 0.05). There were no significant differences in gender, body mass index, drinking history, smoking history, diabetes, gallbladder size, number of stones, stone diameter, operation time, number of angiography, aspartate aminotransferase (AST), glutamyl transpeptidase (GTP), alanine aminotransferase (ALT), direct bilirubin (DBIL) and total bilirubin (TBIL) levels between the two groups (P>0.05). Young age, combined hypertension, concomitant hyperlipidemia, history of pancreatic disease and frequent intubation were independent risk factors for postoperative pancreatitis after DCBDSR. Conclusion Young age, concomitant hypertension, concomitant hyperlipidemia, history of pancreatic disease and frequent intubation are risk factors for developing pancreatitis after DCBDSR.

Key words: gallstones, pancreatitis, duodenoscopes, root cause analysis, common bile duct stone surgery

CLC Number:

R576，R575.6

Figures/Tables 3

References 11

[1]	马亮亮, 沈建伟, 张春艳, 等. 腹腔镜、胆道镜、胃镜三镜联合治疗胆囊结石伴胆总管结石的疗效分析[J]. 中国中西医结合外科杂志, 2023, 29(5):585-589.
	MA L L, SHEN J W, ZHANG C Y, et al. Analysis of the therapeutic effect of laparoscopic, cholangioscopy, and gastroscopy combined treatment for gallstones with common bile duct stones[J]. Chinese Journal of Integrative Surgery, 2023, 29(5):585-589. doi:10.3969/j.issn.1007-6948.2023.05.003.
[2]	BISOGNI D, MANETTI R, TALAMUCCI L, et al. Efficacy and indications of dilation-assisted stone extraction for retrieval of difficult common bile duct stones: Results and data analysis of a single Italian referral center for bilio-pancreatic disease treatment[J]. Minerva Med, 2021, 112(5):653-655. doi:10.23736/S0026-4806.19.06100-7.
[3]	梁斌, 姜永斌, 郑娇娇. LC+LCBDE与ERCP+LC治疗胆囊结石合并胆总管结石的效果及机制分析[J]. 川北医学院学报, 2022, 37(10):1296-1299.
	LIANG B, JIANG Y B, ZHENG J J. Clinical effect and mechanism of LC+LCBDE and ERCP+LC on chole-cystolithiasis complicated with choledocholithiasis[J]. Journal of North Sichuan Medical College, 2022, 37(10):1296-1299. doi:10.3969/j.issn.1005-3697.2022.10.015.
[4]	胡云龙, 宋正伟, 龙昊, 等. 不同胆总管取石术联合腹腔镜胆囊切除术治疗胆囊结石合并胆总管结石的疗效比较[J]. 成都医学院学报, 2021, 16(1):46-49,53.
	HU Y L, SONG Z W, LONG H, et al. Comparison of therapeutic effects of different choledocholithotomy combined with laparoscopic cholecystectomy for cholecystolithiasis with choledocholithiasis[J]. Journal of Chengdu Medical College, 2021, 16(1):46-49,53. doi:10.3969/j.issn.1674-2257.2021.01.011.
[5]	樊艳华, 刘鸿飞, 房龙, 等. 内镜下十二指肠乳头括约肌切开取石术后胰腺炎影响因素分析[J]. 中国内镜杂志, 2016, 22(11):46-50.
	FAN Y H, LIU H F, FANG L, et al. Analysis of influence factors of post-endoscopic sphincterotomy pancreatitis for choledocholithiasis[J]. China Journal of Endoscopy, 2016, 22(11):46-50. doi:10.3969/j.issn.1007-1989.2016.11.011.
[6]	中华医学会消化内镜学分会ERCP学组, 中国医师协会消化医师分会胆胰学组, 国家消化系统疾病临床医学研究中心. ERCP诊治指南(2018版)[J]. 中国实用内科杂志, 2018, 38(11):1041-1072.
	ERCP Group, Digestive Endoscopy Branch, Chinese Medical Association, Biliary and Pancreatic Group of Digestive Physicians Branch of Chinese Medical Doctor Association, National Clinical Medical Research Center for Digestive System Diseases. Chinese guidelines for ERCP(2018)[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(11):1041-1072. doi:10.19538/j.nk2018110167.
[7]	吕新远, 万品文, 万春. 老年胆囊结石合并胆总管结石患者腹腔镜微创取石术后发生胰腺炎的危险因素及其预测效能[J]. 河南医学研究, 2024, 33(5):868-872.
	LV X Y, WAN P W, WAN C. Risk factors and predictive efficacy of pancreatitis after laparoscopic minimally invasive lithotomy in elderly patients with gallbladder stones and common bile duct stones[J]. Henan Medical Research, 2024, 33(5):868-872. doi:10.3969/j.issn.1004-437X.2024.05.022.
[8]	TANG Y, WU Z Y, DENG X J, et al. Removal of an impacted apricot pit from a scarring duodenal stenosis using the endoscopic retrograde cholangiopancreatography (ERCP) stone extraction technique[J]. Rev Esp Enferm Dig, 2024, 116(9):505-506. doi:10.17235/reed.2023.10019/2023.
[9]	徐晓丹, 陈波, 戴建军, 等. 内镜下十二指肠乳头球囊大扩张术联合小切口EST对胆总管大结石取石术后胰腺炎的防治作用[J]. 中华胰腺病杂志, 2018, 18(5):341-343.
	XU X D, CHEN B, DAI J J, et al. The preventive and therapeutic effects of endoscopic balloon dilation of the duodenal papilla combined with small incision EST on postoperative pancreatitis in patients with common bile duct stones after stone removal surgery[J]. Chinese Journal of Pancreatic Diseases, 2018, 18(5):341-343. doi:10.3760/cma.j.issn.1674-1935.2018.05.012.
[10]	陈小龙, 潘燕华, 张鸣青. ERCP术后轻症胰腺炎行腹腔镜胆囊切除术的手术时机[J]. 中华胰腺病杂志, 2022, 22(1):68-71.
	CHEN X L, PAN Y H, ZHANG M Q. The timing of laparoscopic cholecystectomy for mild pancreatitis after ERCP surgery[J]. Chinese Journal of Pancreatic Diseases, 2022, 22(1):68-71. doi:10.3760/cma.j.cn115667-20210128-00027.
[11]	葛大赫, 许春进. ERCP联合内镜乳头括约肌切开取石术治疗胆源性胰腺炎患者的临床效果分析[J]. 现代诊断与治疗, 2022, 33(2):261-263.
	GE D H, XU C J. Clinical analysis of ERCP combined with endoscopic sphincterotomy for the treatment of biliary pancreatitis patients[J]. Modern Diagnosis & Treatment, 2022, 33(2):261-263.

组别		n	男性		年龄/岁		BMI/（kg/m²）		饮酒史		吸烟史		合并高血压		合并糖尿病
无胰腺炎组		351	200（57.0）		42.72±6.23		21.92±2.34		78（22.2）		104（29.6）		27（7.7）		37（10.5）
胰腺炎组		36	23（63.9）		38.97±5.81		22.31±2.65		10（27.8）		13（36.1）		24（66.7）		8（22.2）
χ²或t			0.638		3.460^＊＊		0.940		1.433		0.650		94.164^＊＊		3.273
组别	合并高脂血症			结石数量/枚		结石直径/cm		胰腺病史		手术时间/min		造影次数/次		插管次数/次
无胰腺炎组	56（15.9）			2.43±0.78		1.19±0.32		13（3.7）		94.52±28.97		2.28±0.56		1.97±0.65
胰腺炎组	22（61.1）			2.54±0.61		1.24±0.35		15（41.7）		98.87±21.26		2.37±0.48		3.18±0.42
χ²或t	41.373^＊＊			0.821		0.885		64.569^＊＊		0.877		0.930		10.930^＊＊

组别		n	男性		年龄/岁		BMI/（kg/m²）		饮酒史		吸烟史		合并高血压		合并糖尿病
无胰腺炎组		351	200（57.0）		42.72±6.23		21.92±2.34		78（22.2）		104（29.6）		27（7.7）		37（10.5）
胰腺炎组		36	23（63.9）		38.97±5.81		22.31±2.65		10（27.8）		13（36.1）		24（66.7）		8（22.2）
χ²或t			0.638		3.460^＊＊		0.940		1.433		0.650		94.164^＊＊		3.273
组别	合并高脂血症			结石数量/枚		结石直径/cm		胰腺病史		手术时间/min		造影次数/次		插管次数/次
无胰腺炎组	56（15.9）			2.43±0.78		1.19±0.32		13（3.7）		94.52±28.97		2.28±0.56		1.97±0.65
胰腺炎组	22（61.1）			2.54±0.61		1.24±0.35		15（41.7）		98.87±21.26		2.37±0.48		3.18±0.42
χ²或t	41.373^＊＊			0.821		0.885		64.569^＊＊		0.877		0.930		10.930^＊＊

组别	n	AST/（U/L）	GTP/（U/L）	ALT/（U/L）	DBIL/（μmol/L）	TBIL/（μmol/L）
无胰腺炎组	351	39.94±12.13	164.92±58.49	81.98±26.14	8.19±2.34	19.97±4.76
胰腺炎组	36	43.24±13.76	175.24±43.52	89.96±23.21	8.74±2.56	20.81±4.53
t		1.535	1.029	1.761	1.331	1.013

组别	n	AST/（U/L）	GTP/（U/L）	ALT/（U/L）	DBIL/（μmol/L）	TBIL/（μmol/L）
无胰腺炎组	351	39.94±12.13	164.92±58.49	81.98±26.14	8.19±2.34	19.97±4.76
胰腺炎组	36	43.24±13.76	175.24±43.52	89.96±23.21	8.74±2.56	20.81±4.53
t		1.535	1.029	1.761	1.331	1.013

因素	β	SE	Wald χ²	P	OR	OR 95%CI
年龄	-0.114	0.047	5.980	0.014	0.892	0.814~0.978
高血压	1.978	0.796	6.172	0.013	7.227	1.518~34.403
高脂血症	2.352	0.748	9.885	0.002	10.504	2.425~45.502
胰腺病史	3.975	1.365	8.486	0.004	53.253	3.671~772.455
插管次数	5.195	1.424	13.300	<0.001	180.327	11.056~2 941.200
常数项	-13.732	4.369	9.881	0.002	<0.001